(PDF) The “Real-World” Efficacy and Safety of DAAs for the

The “Real-World” Efficacy and Safety of DAAs for the Treatment of HCV Patients Throughout Japan

Journal of Gastroenterology - Germany

doi 10.1007/s00535-018-1493-8

Full Text

Abstract

Available in full text

Categories

Gastroenterology

Date

July 6, 2018

Authors

Nobuyuki Enomoto

Publisher

Springer Science and Business Media LLC

Related search

Efficacy and Tolerability of DAAs in HCV-monoinfected and HCV/HIV-coinfected Patients With Psychiatric Disorders

BMC Infectious Diseases

Infectious Diseases

English

The Efficacy and Safety of Elbasvir/Grazoprevir Treatment in HCV Genotype 1 Patients in Taiwan

Journal of Medical Virology

Infectious Diseases

English

The Real-World Efficacy and Safety of Direct-Acting Oral Antiviral Treatment in Chronic Hepatitis C Genotype 1 Patients in Turkey

Cumhuriyet Medical Journal

English

Comparison of Renal Safety and Efficacy of Telbivudine, Entecavir and Tenofovir Treatment in Chronic Hepatitis B Patients: Real World Experience

Clinical Microbiology and Infection

Infectious Diseases

English

Response Prediction for Chronic HCV Genotype 4 Patients to DAAs

International Journal of Advanced Computer Science and Applications

Computer Science

English

Safety and Efficacy of a Device to Narrow the Coronary Sinus for the Treatment of Refractory Angina: A Single-Centre Real-World Experience

Netherlands Heart Journal

Cardiovascular Medicine

English

Real-World Safety of Treatment With Mepolizumab and Reslizumab in Patients With Severe Eosinophilic Asthma

Journal of Allergy and Clinical Immunology

English

Efficacy and Safety of Anagrelide as a First‐line Drug in Cytoreductive Treatment‐naïve Essential Thrombocythemia Patients in a Real‐world Setting

European Journal of Haematology

English

Safety and Efficacy of Colesevelam HCl in the Treatment of Elderly Patients

Drugs and Aging

English